Cardlytics Inc Dossier - Source-backed chat

Cardlytics Inc

CDLXNASDAQ

SectorCommunication Services

IndustryAdvertising

Beta (adjusted)0.78

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $2.64Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $15.5M

Enterprise Value $171.9M

Shares Outstanding 5.9M diluted

Moat Rating None

Next Earnings Date4 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Cardlytics is undergoing a critical operational reset following the loss of its major financial institution partner, Bank of America, in January 2026. While Q1 2026 results showed severe year-over-year declines in billings (-37%) and revenue (-39%), the company demonstrated strong operational discipline by turning Adjusted EBITDA positive at $0.2 million and achieving a record adjusted contribution margin of 60.6%. The successful divestiture of the Bridg asset in March 2026 has streamlined the business and bolstered the balance sheet. However, near-term growth remains constrained by partner restrictions and a reduced user base, making the stock a speculative turnaround play that warrants a Hold rating until sustainable self-funded growth is established.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$4.00

Mean target$6.00

High · most bullish analyst$10.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The loss of Bank of America in early 2026 continues to severely depress domestic billings and qualified user metrics. The company struggles to onboard new financial institution portfolios, and sequential growth targets fail to materialize. Continued cash burn and listing pressures from the Nasdaq minimum bid price requirement lead to further capital structure dilution or delisting risks.

Base CaseCentral scenario

The company successfully stabilizes its core platform with remaining major FI partners (Chase, Wells Fargo, American Express) and delivers on its commitment to sequential quarterly growth throughout 2026. Operational efficiencies and cloud optimizations sustain near-breakeven Adjusted EBITDA, while international expansion (particularly in the U.K.) offsets some domestic headwinds.

Bull CaseUpside scenario

Cardlytics successfully scales its new Cardlytics Rewards Platform (CRP) and expands its partnership with American Express and other neobanks, driving rapid domestic recovery. The U.K. business continues its high-growth trajectory (+21% YoY), and aggressive cost-cutting measures lead to positive Adjusted EBITDA and self-sustaining free cash flow sooner than expected.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong operational cost discipline, leading to positive Adjusted EBITDA of $0.2 million in Q1 2026 despite a 39% drop in revenue.
Streamlined corporate focus and strengthened balance sheet following the completed divestiture of Bridg assets in March 2026.
Robust international performance, with the U.K. business delivering over 21% year-over-year revenue growth in Q1 2026.

Key Investment Risks

High concentration of and dependence on a limited number of major financial institution partners (Chase, Wells Fargo, American Express).
Near-term pressure on billings and qualified user metrics due to the exit of Bank of America campaigns in January 2026.
Speculative turnaround profile with historical net losses and ongoing partner-imposed restrictions on promotional campaigns.

Thesis Invalidation Triggers

Loss or material negative modification of agreements with Chase or Wells Fargo.
Inability to maintain positive Adjusted EBITDA or sequential quarterly growth in the latter half of 2026.
Failure to maintain Nasdaq listing compliance if the stock price falls back below the $1.00 threshold.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.